Parents’ perceptions and intention to vaccinate their children under 12 years of age against COVID-19: A cross sectional study in Peru

• Autor(a) principal: Zamora, Jose Gonzales
• Data de Publicação: 2022
• Outros Autores: Moreno, David Soriano, Soriano, Anderson, Ponce-Rosas, Linda, De-Los-Ríos-Pinto , Abraham, Murrieta-Ruiz, Valentina, Morocho-Alburqueque, Noelia, Caira-Chuquineyra, Brenda, Alave-Rosas, Jorge
• Tipo de documento: preprint
• Idioma: spa
• Título da fonte: SciELO Preprints
• Texto Completo: https://preprints.scielo.org/index.php/scielo/preprint/view/3467
• topic: Vaccine; COVID-19; intention; perception; children; Peru; Vacuna; COVID-19; intención; percepción; niños; Perú

Objectives: To evaluate the perceptions and intention of parents to vaccinate their children under 12 years of age. Methodology: Analytical cross-sectional study based on an online survey that collected the parents’ perception on the risk of their children getting COVID-19, on the need of vaccination and on the development of adverse events related to the vaccine. We evaluated the factors associated with the intention to vaccinate through crude (cPR) and adjusted prevalence rates (aPR), with confidence interval of 95% (CI 95%) Results: 83.5% of respondents had the intention of vaccinating their children under 12 years of age. In the multivariate analysis, the factors associated with an decrease in the intention to vaccinate were to think that the vaccine is not necessary (aPR 0.65; 95% CI 0.44 – 0.94), that it would not protect (aPR: 0.14; 95% CI 0.03 – 0.63) , that it would not be safe (aPR: 0.80; 95% CI 0.70 – 0.92) and that it would cause long-term side effects (aPR: 0.92; 95% CI 0.85 – 1.00). On the other hand, living on the highlands or jungle was associated with an increase on the intention. Conclusions: In Peru, 16.5% of parents would not vaccinate their children under 12 years of age, because they perceive that the vaccine is not necessary and would not protect against COVID-19. In addition, they expressed concerns about the development of possible adverse events.